Next Article in Journal
Clinical Relevance of Resection Margins in Patients with Total Laryngectomy or Laryngopharyngectomy
Previous Article in Journal
Bimodal Effect of NKG2A Blockade on Intratumoral and Systemic CD8 T Cell Response Induced by Cancer Vaccine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109

by
Luigi Corsaro
1,2,†,
Davide Gentilini
1,3,*,
Luciano Calzari
3 and
Vincenzo Sandro Gambino
1,4,†
1
Department of Brain and Behavioral Sciences, Università di Pavia, 27100 Pavia, Italy
2
Centro Diagnostico Italiano, Dipartimento di Genetica Molecolare, 20100 Milano, Italy
3
Bioinformatics and Statistical Genomics Unit, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy
4
Ospedale di Rivoli, 10098 Rivoli, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2024, 16(11), 2037; https://doi.org/10.3390/cancers16112037
Submission received: 10 May 2024 / Accepted: 13 May 2024 / Published: 28 May 2024
Additional Affiliation(s)
In the published article [1], there was an error regarding the affiliations for Luigi Corsaro and Vincenzo Sandro Gambino.
The correct affiliations are listed below:
Luigi Corsaro 1,2,†
1 Department of Brain and Behavioral Sciences, Università di Pavia, 27100 Pavia, Italy
2 Centro Diagnostico Italiano, Dipartimento di Genetica Molecolare, 20100 Milano, Italy
Vincenzo Sandro Gambino 1,4,†
1 Department of Brain and Behavioral Sciences, Università di Pavia, 27100 Pavia, Italy
4 Ospedale di Rivoli, 10098 Rivoli, Italy
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Addition of Authors
Davide Gentilini and Luciano Calzari were not included as authors in the original publication. The corrected Author Contributions Statement is as follows:
Author Contributions: Conceptualization, L.C. (Luigi Corsaro) and V.S.G.; Methodology, L.C. (Luigi Corsaro), D.G., L.C. (Luciano Calzari) and V.S.G.; Validation, D.G. and L.C. (Luciano Calzari); Software, L.C. (Luigi Corsaro), D.G. and L.C. (Luciano Calzari); Formal analysis, L.C. (Luigi Corsaro) and V.S.G.; Investigation, V.S.G.; Resources, L.C. (Luigi Corsaro) and V.S.G.; Data curation, L.C. (Luigi Corsaro); Writing—original draft, L.C. (Luigi Corsaro) and V.S.G.; Writing—review and editing, L.C. (Luigi Corsaro) and V.S.G.; Visualization, L.C. (Luigi Corsaro); Supervision, L.C. (Luigi Corsaro), D.G., L.C. (Luciano Calzari) and V.S.G. All authors have read and agreed to the published version of the manuscript.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Corsaro, L.; Gentilini, D.; Calzari, L.; Gambino, V.S. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Corsaro, L.; Gentilini, D.; Calzari, L.; Gambino, V.S. Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. Cancers 2024, 16, 2037. https://doi.org/10.3390/cancers16112037

AMA Style

Corsaro L, Gentilini D, Calzari L, Gambino VS. Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. Cancers. 2024; 16(11):2037. https://doi.org/10.3390/cancers16112037

Chicago/Turabian Style

Corsaro, Luigi, Davide Gentilini, Luciano Calzari, and Vincenzo Sandro Gambino. 2024. "Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109" Cancers 16, no. 11: 2037. https://doi.org/10.3390/cancers16112037

APA Style

Corsaro, L., Gentilini, D., Calzari, L., & Gambino, V. S. (2024). Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. Cancers, 16(11), 2037. https://doi.org/10.3390/cancers16112037

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop